Abbott ramps up Libre 3 production amid shortages
Sep 20, 2024 · MedTech industry news. “Essentially, some patients are seeing delays in their scripts getting filled at certain U.S. retail pharmacies due to a low on-shelf inventory, and while there are likely some minor supply issues causing these script delays, demand also has been very strong as Abbott continues to gain share in the U.S.,” Marcus wrote on Thursday.
Medical Technology News | MedTech Dive
MedTech Dive provides medical technology news and analysis for industry professionals. We cover medical devices, diagnostics, digital health, FDA regulation and compliance, imaging, and more.
Medtech companies lay off thousands in 2024, continuing last …
Feb 12, 2024 · The latest announcements continue a top industry trend from 2023.A MedTech Dive analysis of state Worker Adjustment and Retraining Notification databases found that medical device companies announced layoffs for more than 14,000 employees between Jan. 1, 2023, and June 30, 2024.. Last year, Medtronic, Abbott, Boston Scientific and Johnson & Johnson were among a long list of companies that ...
The number of AI medical devices has spiked in the past decade
Oct 9, 2024 · The number of medical devices with artificial intelligence technology has risen sharply in the past decade. The Food and Drug Administration has authorized 950 AI or machine learning-enabled devices as of Aug. 7, 2024, according to the agency’s database. While the FDA authorized the first AI-enabled device in 1995, the number of …
Thermo Fisher eliminating 160 jobs, closing Massachusetts facility
Nov 15, 2024 · MedTech industry news. Dive Insight: Demand for viral vectors, which are used in the production of cell and gene therapies, outpaced supply in the late 2010s and into the 2020s as more candidates entered clinical development. Thermo Fisher and other contract development and manufacturing organizations responded by investing in production facilities.
What’s next at Masimo after CEO Kiani’s exit? | MedTech Dive
Sep 30, 2024 · Masimo’s leadership transition brings a two-year boardroom feud to a close, but questions remain about the path forward in the wake of CEO Joe Kiani’s exit.
Senseonics receives FDA clearance for one-year CGM
Sep 17, 2024 · Dive Brief: Senseonics and commercial partner Ascensia Diabetes Care received clearance from the Food and Drug Administration for the first implantable glucose sensor that can be worn for one year, doubling the wear time of Senseonics’ current sensor.; The continuous glucose monitor (CGM), called Eversense 365, is implanted just under the skin.
Stryker adds devices to remove brain tumors, clots with Nico buy
Sep 23, 2024 · Dive Brief: Stryker has struck its fourth takeover in as many months, acquiring Nico Corporation to add minimally invasive solutions for brain tumor removal and stroke care to its portfolio.; Nico sells devices for navigating through the brain, visualizing the organ, removing tumors and clots and collecting tissue.
Baxter ups IV fluid allocations amid supply shortages
Oct 10, 2024 · Baxter said Wednesday it would increase allocation levels of certain IV fluids as the U.S. manages supply shortages after the company’s largest manufacturing plant was damaged by Hurricane Helene.. The company increased allocation levels of its “highest demand” IV fluids from 40% to 60% for direct customers and from 10% to 60% for distributors, effective Wednesday, according to the update.
Medtronic buys surgical instrument developer Fortimedix
Nov 22, 2024 · Dive Insight: Fortimedix has kept a low profile in recent years. The Dutch medtech company put out a series of press releases in 2016 and 2017, when it raised 11 million euros, received a CE mark and launched a single-port Symphonx surgery system in the U.S.. Physicians published a paper in 2020 about the learning curve for new users of the surgery system.